ZNTL logo

Zentalis Pharmaceuticals (ZNTL) Company Overview

Profile

Full Name:

Zentalis Pharmaceuticals, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

April 3, 2020

Indexes:

Not included

Description:

Zentalis Pharmaceuticals is a biopharmaceutical company focused on developing innovative cancer treatments. They create targeted therapies to improve patient outcomes and address unmet medical needs in oncology. Their research aims to advance new medicines that can effectively fight various types of cancer.

Events Calendar

Earnings

Next earnings date:

Feb 27, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Feb 27, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 30, 25 Wells Fargo
Equal-Weight
Jan 29, 25 HC Wainwright & Co.
Buy
Jan 28, 25 UBS
Neutral
Nov 15, 24 HC Wainwright & Co.
Buy
Nov 15, 24 Guggenheim
Buy
Sep 16, 24 Oppenheimer
Outperform
Aug 12, 24 Wedbush
Neutral
Aug 12, 24 HC Wainwright & Co.
Buy
Jun 20, 24 UBS
Neutral
Jun 18, 24 Wells Fargo
Equal-Weight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Zentalis Pharmaceuticals?
  • Does Zentalis Pharmaceuticals pay dividends?
  • What sector is Zentalis Pharmaceuticals in?
  • What industry is Zentalis Pharmaceuticals in?
  • What country is Zentalis Pharmaceuticals based in?
  • When did Zentalis Pharmaceuticals go public?
  • Is Zentalis Pharmaceuticals in the S&P 500?
  • Is Zentalis Pharmaceuticals in the NASDAQ 100?
  • Is Zentalis Pharmaceuticals in the Dow Jones?
  • When was Zentalis Pharmaceuticals's last earnings report?
  • When does Zentalis Pharmaceuticals report earnings?
  • Should I buy Zentalis Pharmaceuticals stock now?

What is the ticker symbol for Zentalis Pharmaceuticals?

The ticker symbol for Zentalis Pharmaceuticals is NASDAQ:ZNTL

Does Zentalis Pharmaceuticals pay dividends?

No, Zentalis Pharmaceuticals does not pay dividends

What sector is Zentalis Pharmaceuticals in?

Zentalis Pharmaceuticals is in the Healthcare sector

What industry is Zentalis Pharmaceuticals in?

Zentalis Pharmaceuticals is in the Biotechnology industry

What country is Zentalis Pharmaceuticals based in?

Zentalis Pharmaceuticals is headquartered in United States

When did Zentalis Pharmaceuticals go public?

Zentalis Pharmaceuticals's initial public offering (IPO) was on April 3, 2020

Is Zentalis Pharmaceuticals in the S&P 500?

No, Zentalis Pharmaceuticals is not included in the S&P 500 index

Is Zentalis Pharmaceuticals in the NASDAQ 100?

No, Zentalis Pharmaceuticals is not included in the NASDAQ 100 index

Is Zentalis Pharmaceuticals in the Dow Jones?

No, Zentalis Pharmaceuticals is not included in the Dow Jones index

When was Zentalis Pharmaceuticals's last earnings report?

Zentalis Pharmaceuticals's most recent earnings report was on Nov 12, 2024

When does Zentalis Pharmaceuticals report earnings?

The next expected earnings date for Zentalis Pharmaceuticals is Feb 27, 2025

Should I buy Zentalis Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions